ZA200200094B - Nitrogen containing heterobicycles as factor xa inhibitors. - Google Patents

Nitrogen containing heterobicycles as factor xa inhibitors.

Info

Publication number
ZA200200094B
ZA200200094B ZA200200094A ZA200200094A ZA200200094B ZA 200200094 B ZA200200094 B ZA 200200094B ZA 200200094 A ZA200200094 A ZA 200200094A ZA 200200094 A ZA200200094 A ZA 200200094A ZA 200200094 B ZA200200094 B ZA 200200094B
Authority
ZA
South Africa
Prior art keywords
inhibitors
nitrogen containing
factor
heterobicycles
same
Prior art date
Application number
ZA200200094A
Other languages
English (en)
Inventor
Irina C Jacobson
Mimi L Quan
Original Assignee
Bristol Meyers Squibb Pharma C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Meyers Squibb Pharma C filed Critical Bristol Meyers Squibb Pharma C
Publication of ZA200200094B publication Critical patent/ZA200200094B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200200094A 1999-07-16 2002-01-04 Nitrogen containing heterobicycles as factor xa inhibitors. ZA200200094B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14434499P 1999-07-16 1999-07-16

Publications (1)

Publication Number Publication Date
ZA200200094B true ZA200200094B (en) 2003-04-30

Family

ID=22508178

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200200094A ZA200200094B (en) 1999-07-16 2002-01-04 Nitrogen containing heterobicycles as factor xa inhibitors.

Country Status (18)

Country Link
US (2) US6429205B1 (ko)
EP (1) EP1196412B1 (ko)
JP (1) JP2004507439A (ko)
KR (1) KR20030011268A (ko)
CN (1) CN1454211A (ko)
AT (1) ATE268766T1 (ko)
AU (1) AU2481501A (ko)
BR (1) BR0013200A (ko)
CA (1) CA2380727A1 (ko)
DE (1) DE60011430T2 (ko)
ES (1) ES2222257T3 (ko)
HK (1) HK1045502B (ko)
IL (1) IL147317A0 (ko)
MX (1) MXPA02000537A (ko)
NO (1) NO20020217L (ko)
PL (1) PL357108A1 (ko)
WO (1) WO2001005784A1 (ko)
ZA (1) ZA200200094B (ko)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6339099B1 (en) * 1997-06-20 2002-01-15 Dupont Pharmaceuticals Company Guanidine mimics as factor Xa inhibitors
JP2003502314A (ja) 1999-06-14 2003-01-21 イーライ・リリー・アンド・カンパニー 化合物
EP1255741A2 (en) 2000-02-01 2002-11-13 Cor Therapeutics, Inc. 2- 1H]-QUINOLONE AND 2- 1H]-QUINOXALONE INHIBITORS OF FACTOR Xa
WO2001057003A1 (en) * 2000-02-01 2001-08-09 Cor Therapeutics, Inc. 3,4-DIHYDRO-2H-BENZO[1,4]OXAZINE INHIBITORS OF FACTOR Xa
EP1283199A4 (en) * 2000-05-16 2003-12-17 Takeda Chemical Industries Ltd MELANIN CONCENTRATION HORMONE ANTAGONIST
ATE373655T1 (de) 2000-06-23 2007-10-15 Bristol Myers Squibb Pharma Co 1-(heteroaryl-phenyl)-kondensierte pyrazol- derivate als factor xa inhibitoren
JP2004501913A (ja) 2000-06-23 2004-01-22 ブリストル−マイヤーズ　スクイブ　ファーマ　カンパニー ヘテロアリール−フェニル置換Ｘａ因子阻害剤
TWI331526B (en) 2001-09-21 2010-10-11 Bristol Myers Squibb Pharma Co Lactam-containing compounds and derivatives thereof as factor xa inhibitors
CN110894196A (zh) 2001-09-21 2020-03-20 百时美-施贵宝控股爱尔兰无限公司 含有内酰胺的化合物及其衍生物作为Xa因子的抑制剂
WO2003048081A2 (en) 2001-12-04 2003-06-12 Bristol-Myers Squibb Company Glycinamides as factor xa inhibitors
TW200302225A (en) 2001-12-04 2003-08-01 Bristol Myers Squibb Co Substituted amino methyl factor Xa inhibitors
WO2003062226A1 (en) 2002-01-22 2003-07-31 E. I. Du Pont De Nemours And Company Quinazoline(di) ones for invertebrate pest control
RS51097B (sr) 2002-03-26 2010-10-31 Boehringer Ingelheim Pharmaceuticals Inc. Glukokortikoidni mimetici,postupci za njihovo dobijanje, farmaceutski preparati i njihova primena
AU2003273179A1 (en) 2002-05-10 2003-12-12 Bristol-Myers Squibb Company 1,1-disubstituted cycloalkyl derivatives as factor xa inhibitors
ATE403648T1 (de) * 2002-08-21 2008-08-15 Boehringer Ingelheim Pharma Substituierte dihydrochinoline als glucocorticoid-mmimetika,verfahren zu deren herstellung, pharmazeutische zubereitungen und deren verwendung
PT1569912E (pt) 2002-12-03 2015-09-15 Pharmacyclics Llc Derivados 2-(2-hidroxibifenil-3-il)-1h-benzoimidazole-5- carboxamidina como inibidores do fator viia
US7429581B2 (en) 2002-12-23 2008-09-30 Sanofi-Aventis Deutschland Gmbh Pyrazole-derivatives as factor Xa inhibitors
AU2003292218A1 (en) * 2002-12-23 2004-07-14 Sanofi-Aventis Deutschland Gmbh PYRAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
EP1479678A1 (en) * 2003-05-19 2004-11-24 Aventis Pharma Deutschland GmbH Pyrazole-derivatives as factor xa inhibitors
US7122557B2 (en) 2003-03-18 2006-10-17 Bristol-Myers Squibb Company Sulfonyl-amidino-containing and tetrahydropyrimidino-containing compounds as factor Xa inhibitors
US7129264B2 (en) * 2003-04-16 2006-10-31 Bristol-Myers Squibb Company Biarylmethyl indolines and indoles as antithromboembolic agents
UY28526A1 (es) 2003-09-24 2005-04-29 Boehringer Ingelheim Pharma Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
US20050124664A1 (en) * 2003-10-30 2005-06-09 Eric Sartori Urea thiadiazole inhibitors of plasminogen activator inhibior-1
US7795272B2 (en) 2004-03-13 2010-09-14 Boehringer Ingelheim Pharmaceutical, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
CN101087609B (zh) * 2004-10-26 2012-11-14 詹森药业有限公司 因子Xa化合物
ES2326907T3 (es) 2004-12-27 2009-10-21 Boehringer Ingelheim Pharmaceuticals Inc. Mimeticos de glucocorticoides, metodos para su preparacion, composiciones farmaceuticas y su uso.
GT200600042A (es) * 2005-02-10 2006-09-27 Aventis Pharma Inc Compuestos de bis arilo y heteroarilo sustituido como antagonistas selectivos de 5ht2a
DE102005038947A1 (de) 2005-05-18 2006-11-30 Grünenthal GmbH Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln
MX2009005264A (es) 2006-12-06 2009-05-28 Boehringer Ingelheim Int Mimeticos de glucocorticoides, metodos para su fabricacion, composiciones farmaceuticas y usos de los mismos.
AU2008251557B2 (en) * 2007-05-10 2012-12-06 Albany Molecular Research, Inc. Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
MX2010013095A (es) 2008-06-06 2010-12-21 Boehringer Ingelheim Int Mimeticos de glucocorticoides, metodos para su fabricacion, composiciones farmaceuticas y usos de los mismos.
EP2865671B1 (en) * 2012-06-22 2017-11-01 Sumitomo Chemical Company, Ltd Fused heterocyclic compound
KR102282673B1 (ko) * 2016-05-23 2021-07-27 더 락커펠러 유니버시티 자가면역 질병의 치료를 위한 아미노아실인다졸 면역조절제

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0874629B1 (en) 1995-12-21 2004-05-19 Bristol-Myers Squibb Pharma Company ISOXAZOLINE, ISOTHIAZOLINE AND PYRAZOLINE FACTOR Xa INHIBITORS
JP2001506271A (ja) 1996-12-23 2001-05-15 デュポン ファーマシューティカルズ カンパニー Ｘａ因子阻害剤としての酸素またはイオウを含む複素環式芳香族化合物
SK86699A3 (en) * 1996-12-23 2000-11-07 Du Pont Pharm Co Nitrogen containing heteroaromatics as factor xa inhibitors
ZA985247B (en) * 1997-06-19 1999-12-17 Du Pont Merck Pharma Guanidine mimics as factor Xa inhibitors.
IL133526A0 (en) 1997-06-19 2001-04-30 Du Pont Pharm Co Inhibitors of factor xa with a neutral p1 specificity group
JP2001526268A (ja) 1997-12-22 2001-12-18 デュポン ファーマシューティカルズ カンパニー Ｘａ因子阻害剤としての、オルト−置換Ｐ１を有する、窒素含有複素環式芳香族化合物

Also Published As

Publication number Publication date
NO20020217L (no) 2002-03-15
US20030096820A1 (en) 2003-05-22
ATE268766T1 (de) 2004-06-15
DE60011430T2 (de) 2005-07-07
WO2001005784A1 (en) 2001-01-25
BR0013200A (pt) 2002-05-07
NO20020217D0 (no) 2002-01-15
EP1196412A1 (en) 2002-04-17
KR20030011268A (ko) 2003-02-07
US6429205B1 (en) 2002-08-06
PL357108A1 (en) 2004-07-12
MXPA02000537A (es) 2004-09-10
US6716841B2 (en) 2004-04-06
HK1045502B (zh) 2004-12-10
CA2380727A1 (en) 2001-01-25
HK1045502A1 (en) 2002-11-29
CN1454211A (zh) 2003-11-05
ES2222257T3 (es) 2005-02-01
DE60011430D1 (de) 2004-07-15
JP2004507439A (ja) 2004-03-11
AU2481501A (en) 2001-02-05
IL147317A0 (en) 2002-08-14
EP1196412B1 (en) 2004-06-09

Similar Documents

Publication Publication Date Title
IL147317A0 (en) NITROGEN CONTAINING HETEROBICYCLES AS FACTOR Xa INHIBITORS
WO2002000651A3 (en) Factor xa inhibitors
PL350042A1 (en) Serine protease inhibitors
BG104780A (en) Inhibitors of phospholipase enzymes
GEP20074098B (en) Lactam-containing compounds and derivatives thereof as factor xa inhibitors
ATE244717T1 (de) Inhibitoren des impdh-enzyms
WO2000055124A3 (en) Novel compounds and compositions as protease inhibitors
NO990855L (no) Substituerte sykliske amin-metallprotease-inhibitorer
EP1862457A3 (en) Fluoropyrrolidines as dipeptidyl peptidase inhibitors
IL222773B (en) Biaryl compounds, pharmaceutical preparations containing them, use of such compounds for the manufacture of drugs and in vitro methods and devices using such compounds
WO2005099709A3 (en) Bicyclic heterocycles useful as serine protease inhibitors
DE60324183D1 (en) Aryl-, aryloxy- und alkyloxysubstituierte 1h-indol-3-yl-glyoxylsäurederivateals inhibitoren des plasminogenaktivatorinhibitors-1 (pai-1)
NO983688L (no) Serin-protease-inhibitorer
WO2002080853A3 (en) Fused heterocyclic inhibitors of factor xa
WO2001044172A8 (en) Salicylamides as serine protease and factor xa inhibitors
WO2002020475A3 (en) Inhibitors of serine protease activity of matriptase or mtsp1
IL124883A0 (en) Amidino protease inhibitors and pharmaceutical compositions containing the same
WO2001070204A3 (de) Hochselektive inhibitoren des urokinase-plasminogenaktivators
WO2002002519A3 (en) THROMBIN OR FACTOR Xa INHIBITORS
WO2003015715A3 (en) Tetrahydroquinoline derivatives as antithrombotic agents
AU3864000A (en) Inhibitors of serine protease activity, methods and compositions for treatment of herpes viruses
AU8184301A (en) Inhibitors for the blood-clotting factor xa
AU3719100A (en) Inhibitors of serine protease activity, methods and compositions for treatment of viral infections
WO2002094197A3 (en) Bicyclic inhibitors of factor xa
MXPA04004450A (es) Nuevos compuestos y composiciones como inhibidores de catepsina s.